Advancing personalized medicine: key priorities for clinical studies and funding systems based on a Europe–China collaborative Delphi survey.

Personalized medicine (PM) has the potential to revolutionize healthcare by delivering treatments tailored to individual patients based on their unique characteristics. However, ensuring its effective implementation presents complex challenges, particularly in terms of long-term sustainability. To a...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Public Health Vol. 35; no. 2; pp. 209 - 216
Autores principales: Osti, Tommaso, Savoia, Cosimo, Farina, Sara, Beccia, Flavia, Causio, Francesco Andrea, Wang, Lily, Wang, Wenya, Fotino, Carmen, Cadeddu, Chiara, Ricciardi, Walter, Boccia, Stefania
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA Apr2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184271038&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184271038
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        11011262
        BHW
      jtl: European Journal of Public Health
      issn: 11011262
      maglogo: N
    pubinfo:
      dt: Apr2025
      vid: 35
      iid: 2
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        184271038
        184271038
        184271038
        10.1093/eurpub/ckaf004
        184271038
      ppf: 209
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Advancing personalized medicine: key priorities for clinical studies and funding systems based on a Europe–China collaborative Delphi survey.
      aug:
        au:
          Osti, Tommaso
          Savoia, Cosimo
          Farina, Sara
          Beccia, Flavia
          Causio, Francesco Andrea
          Wang, Lily
          Wang, Wenya
          Fotino, Carmen
          Cadeddu, Chiara
          Ricciardi, Walter
          Boccia, Stefania
        affil: Section of Hygiene, University Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy
      sug:
        subj:
          Individualized Medicine
          Clinical Trials Economics
          Research Support
          Health Priorities Europe
          Health Priorities China
          Collaboration
          International Relations
          Government Programs Europe
          Government Programs China
          Program Implementation
          Human
          Delphi Technique
          Europe
          China
          Health Care Delivery
          Health Resource Allocation
          Health Resource Utilization
          Sustainable Growth
          Study Design
          Diffusion of Innovation
          Funding Source
      ab: Personalized medicine (PM) has the potential to revolutionize healthcare by delivering treatments tailored to individual patients based on their unique characteristics. However, ensuring its effective implementation presents complex challenges, particularly in terms of long-term sustainability. To address these challenges, the IC2PerMed project fosters collaboration between the European Union and China. This study, building on insights from the project, aims to identify key priorities for advancing PM, focusing on Clinical Studies and Funding Systems, with special attention to optimizing resource management, distribution, and protection to support sustainable development. A two-round Delphi survey was conducted to achieve consensus on common priorities among China and Europe related to Clinical Studies and Funding Systems. Consensus was measured using the Content Validity Index, requiring an agreement level of 80% or higher for item inclusion. The survey identified 20 key priorities in PM research, split evenly between research initiatives and funding mechanisms. Notable priorities include developing technology for deep phenotyping, standardizing methodological approaches, and fostering public–private collaborations. In funding, the emphasis was placed on involving patient voices in research design and establishing synergies among funders to support larger projects. The findings underscore the importance of structured collaboration between Europe and China in advancing personalised medicine. By addressing identified priorities in research and funding, this initiative can significantly enhance the efficacy of PM, ultimately improving healthcare outcomes globally. The study sets a precedent for future international partnerships aimed at fostering innovation in health sciences.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N